Molecular Prognostic and Predictive Markers in Triple - Negative Breast Cancer
Triple-negative breast cancer (TNBC) is defined as a molecular subtype of breast cancer that lacks expression of hormone receptors (oestrogen and progesterone receptor) and HER2/neu/ErbB2 protein. It accounts for 15–20% of all invasive breast cancers. The occurrence of TNBC is often associated with...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76435 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Molecular Prognostic and Predictive Markers in Triple - Negative Breast Cancer
- Advances in Molecular and Immunohistochemical Detection of Prognostic and Therapeutic Markers in Breast Cancer
- Radiologic Features of Triple Negative Breast Cancer
- Management of the Triple Negative Locally Advanced Breast Cancer
- Experimental Therapeutics for the Treatment of Triple Negative Breast Cancer
- FZD7 in Triple Negative Breast Cancer Cells
- Molecular Chaperones as Prognostic Markers of Neuroblastoma